| Information | |
|---|---|
| Name of lifestyle | Finasteride |
| Third Class | Benign prostatic hypertrophy(BPH) medication |
| Second Class | Drug |
| First Class | Clinical characteristics |
| Unit | NA |
| Stratification |
12394690:Never; r |
| Type of influence factor | Protective factor |
| Classification of Lifestyles |
Clinical characteristics |
| The affected types of PCa |
Total PCa |
| Number of studies involved | 1 |
| 1 Items, 1 Pages <<Prev 1 Next>> All | |||||||
|---|---|---|---|---|---|---|---|
| Research involved | |||||||
| PMID | First auther | Year | Area | Duration | Study type | Sample size | More |
| 12394690 | J. IRANI, V. RAVERY | 2002 | France | January 1999, June 2000 | questionnaire | 639;659 | baseline outcome |